Cyclacel Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.96M, a 67.6% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$13.4M, a 45.6% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.6M, a 6.4% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$21.2M, a 14.9% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$18.5M, a 119% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$22.6M -$1.36M -6.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$21.2M -$2.74M -14.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$18.5M -$10M -119% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 -$8.45M -$615K -7.85% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$7.83M -$542K -7.44% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$7.29M +$182K +2.44% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$7.47M +$4.32M +36.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 -$11.8M +$2.55M +17.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$14.3M +$5.05M +26% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$19.4M -$9.23M -90.9% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 -$10.2M +$3.03M +23% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 -$13.2M +$2.06M +13.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 -$15.2M +$778K +4.86% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
2010 -$16M Jan 1, 2010 Dec 31, 2010 10-K 2014-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.